Understanding Drug Interactions of Buprenorphine/Naloxone.

  • Published In: MEDSURG Nursing, 2025, v. 34, n. 3. P. 110 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Felicilda Reynaldo, Rhea Faye D.; Kenneally, Maria; Inocian, Ergie P. 3 of 3

Abstract

Buprenorphine/naloxone therapy can result in safety concerns due to its potential drug-drug interactions with central nervous system depressants, serotonergic agents, and CYP3A4 modulators. Nurses play a crucial role in educating patients about the importance of avoiding these high-risk combinations and recognizing early signs of adverse effects. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:MEDSURG Nursing. 2025/05, Vol. 34, Issue 3, p110
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2025
  • ISSN:1092-0811
  • DOI:10.62116/msj.2025.34.3.110
  • Accession Number:185996064
  • Copyright Statement:Copyright of MEDSURG Nursing is the property of Jannetti Publications, Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.